OVID vs ITRM โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
OVID Captures Institutional Edge (3โ1 Pillars ยท 8โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ovid Therapeutics Inc. Common Stock (OVID) driven by superior Valuation, Growth & Margin, Momentum & Technical while ITRM counters with relative strength in Options & Structure. Fundamentally, OVID trades at 1.8x Forward P/E with -4693.7% operating margin (-88.3% YoY revenue) versus ITRM at N/M Forward P/E and -1982.3% operating margin (-100.0% YoY). In options structure, OVID sits in BREAKDOWN (<1st %ile IV; Dealer Gamma Walls on Pro) against ITRM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | OVID | ITRM | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $424.6M | $3.8M | Larger Scale | OVID |
| Trailing P/E Ratio Valuation | 1.8x | N/M | Lower Multiple | OVID |
| Forward P/E Ratio Valuation | 1.8x | N/M | Lower Multiple | OVID |
| Revenue Growth (YoY) Growth | -88.3% | -100.0% | Higher Growth | OVID |
| Operating Margin (TTM) Profitability | -4693.7% | -1982.3% | Higher Margin | ITRM |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -35.4% | -555.7% | Higher ROE | OVID |
| 52-Week Range Position Momentum | 52% ($1โ$3) | 0% ($0โ$1) | Stronger Trend | OVID |
| Beta / 30D Volatility Risk Regime | 1.04ฮฒ ยท 97% Vol | 1.61ฮฒ ยท 508% Vol | Lower Realized Risk | OVID |
| Unified Institutional Score Composite Signal | 52.3 / 100 (HOLD) | 50.5 / 100 (HOLD) | Higher Composite | OVID |